Medico Remedies Ltd has closed its trading window for insiders effective October 1, 2026. The restriction remains in force until 48 hours after the declaration of unaudited financial results for the quarter ended September 30, 2026.

Compliance with Insider Trading Norms

The company issued this intimation pursuant to the SEBI (Prohibition of Insider Trading) Regulations, 2015, as amended. The closure applies to all Insiders, Designated Persons, and their immediate relatives as per the company's Code of Internal Procedures and Conduct.

Key Dates and Restrictions

This procedural step ensures that no insider trading occurs during the sensitive period leading up to and immediately following the release of quarterly performance data. The board meeting to approve these results is expected shortly, though the specific date was not disclosed in this filing.

Medico Remedies held its 32nd Annual General Meeting (AGM) on September 22, 2026, via Video Conferencing. Shareholders adopted the audited financial statements for the fiscal year ended March 31, 2026, and approved key board reappointments.

The meeting was presided over by Haresh Mehta, Chairman and Whole-Time Director. Due to low attendance, only 34 members participated through the virtual platform. The notice convening the meeting and the Auditors' Report were taken as read, with statutory documents available for inspection.

Key resolutions passed

The AGM addressed both ordinary and special business items, focusing on leadership continuity and remuneration adjustments. The company disclosed that all seven resolutions were passed by requisite majority.

Voting participation and breakdown

The company disclosed specific voting data pursuant to SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. A total of 16,439 shareholders were on the record date of September 15, 2026. Voting was conducted via remote e-voting and live e-voting during the meeting.

The scrutiny report highlighted significant promoter support across all resolutions. For the adoption of financial statements, promoters cast 50,937,145 votes in favour, while public non-institutional investors polled 167,626 votes, with only 13 votes against. In contrast, institutional public shareholders did not participate in the voting process for any resolution.

Operational overview and shareholder queries

During the session, the Chairman provided an overview of the company's operations and financial performance for FY26, along with its future outlook. Two registered shareholders raised questions regarding the status of operations at both existing and new manufacturing units. These queries were satisfactorily answered by the Chairman.

Compliance and scrutiny details

Ms. Shreya Shah, a Practicing Company Secretary, served as the Scrutinizer to supervise the e-voting process. The combined report on voting results from remote e-voting and live e-voting was submitted to stock exchanges and published on the company website within two working days of the meeting's conclusion. The meeting commenced at 4:00 pm and concluded at 4:15 pm, with e-voting remaining open for 15 minutes post-AGM.